Official No Sample Clauses

Official No. Title Case Status Designation for purposes of Schedule 3 Case 14 monoclonal TCRs (P32566 / 44172.00.2008) Case14-WO WO 2003/020763 Soluble T cell receptor International phase complete Core Case14-AU 2002321581 Soluble T cell receptor Granted/Registered Core Case14-CA 2457652 Soluble T cell receptor Granted/Registered Core Case14-CN 02819279.6 Soluble T cell receptor Granted/Registered Core Case14-EA 006601 Soluble T cell receptor Granted/Registered Core Case14-EP 1421115 Soluble T cell receptor EP Granted (AT, BE, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, NL, PT, SE, TR) Core Case14-HK 1066018 Soluble T cell receptor Granted/Registered Core Case14-M 160359 Soluble T cell receptor Granted/Registered Core Case14-IN 212621 Soluble T cell receptor Granted/Registered Core Case14-JP 4317940 Soluble T cell receptor Granted/Registered Core Case14-KR 00-0000000 Soluble T cell receptor Granted/Registered Core Case14-MX 246738 Soluble T cell receptor Granted/Registered Core Case14-NO 331877 Soluble T cell receptor Granted/Registered Core Case14-NZ 531208 Soluble T cell receptor Granted/Registered Core Case14-PL 208712 Soluble T cell receptor Granted/Registered Core Case14-SG 102850 Soluble T cell receptor Granted/Registered Core Case14-US 7329731 Soluble T cell receptor Granted/Registered Core Case14-US1 7763718 Soluble T cell receptor Granted/Registered Core Case14-ZA 2004/1197 Soluble T cell receptor Granted/Registered Core Case 18 scTCR (P53462 / 44172.00.2012) Case18-WO WO2004/033685 Single chain recombinant T cell receptors International phase complete Core Case18-AU 2003271904 Single chain recombinant T cell receptors Granted/Registered Core Case18-CA 2501870 Single chain recombinant T cell receptors Granted/Registered Core Case18-CN 200380101143.1 Single chain recombinant T cell receptors Granted/Registered Core Case18-EP 03753742.0 Single chain recombinant T cell receptors Under Examination Core Case18-JP 4436319 Single chain recombinant T cell receptors Granted/Registered Core Case18-IL 167652 Single chain recombinant T cell receptors Granted/Registered Core Case18-IN 227369 Single chain recombinant T cell receptors Granted/Registered Core Case18-NO 2005/2198 Single chain recombinant T cell receptors Under Examination Core Case18-NZ 539225 Single chain recombinant T cell receptors Granted/Registered Core Case18-RU 2355703 Single chain recombinant T cell receptors Granted/Registered Core Case18-US 7569664 Single chain recombinant T cell receptors Grante...
Sample 1
AutoNDA by SimpleDocs
Official No. Title Case Status US1 Case52-US2 8367804 *** Granted/Registered Case52-US3 13/429944 *** Under Examination Case52-ZA 2006/09461 *** Granted/Registered Case53-WO WO2005/114215 *** International phase complete Case53-AU 2005246073 *** Granted/Registered Case53-CA 2567349 *** Granted/Registered Case53-CN 200580015878.1 *** Granted/Registered Case53-EP 1756278 *** EP Granted (CH, DE, FR, GB, IE) Case53-HK 1105995 *** Granted/Registered Case53-JP 4972549 *** Granted/Registered Case53-NZ 550815 *** Granted/Registered Case53-US 7608410 *** Granted/Registered Case53-ZA 2006/09462 *** Granted/Registered Case58-WO WO2006/000830 *** International phase complete ***Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
Sample 1
Official No. Title Case Status Country 101112.0001AU 1025053 ALDEROX KR7 Registered Australia 101112.0001EP 003775822 ALDEROX KR7 Registered European Community 101112.0001IN 1315206 ALDEROX KR7 Application filed India 101112.0001NZ 719884 ALDEROX KR7 Registered New Zealand 101112.0001US 3022028 ALDEROX KR7 Registered United States of America 101112.0002AU 1025054 ALDEROX TSR Registered Australia 101112.0002EP 003778156 ALDEROX TSR Registered European Community 101112.0002IN 1315205 ALDEROX TSR Application filed India 101112.0002NZ 719883 ALDEROX TSR Registered New Zealand 101112.0004US 2905209 ALDEROX Registered United States of America 101112.0006US 2905208 ASA 12 Registered United States of America 101112.0007US 3109303 B20-POWER Registered United States of America 101112.0011T 77/491970 WE MINE WHAT YOU LEFT BEHIND Application allowed United States of America 101112.0012T 77/491973 WE MINE WHAT’S LEFT BEHIND Application allowed United States of America Schedule D Licensed Copyrights None EXHIBIT B [FORM OF CERTIFICATE OF DESIGNATIONS] CERTIFICATE OF DESIGNATIONS OF SERIES A PREFERRED STOCK OF ALDEROX, INC. Alderox, Inc. (the “Company”), a company organized under the laws of the State of Colorado, hereby certifies, pursuant to [Section [ ] of the [Colorado General Corporation Law], that the following resolutions were duly adopted by its Board of Directors (the “Board”) on , 2009:
Sample 1
Official No and the following approximate dimensions and tonnages: Length: 186.92 metres Breadth: 27.80 metres Depth 15.61 metres Gross Tonnage: 23,696.00 tons Net Tonnage: 14,790.00 tons (hereinafter called “the Vessel”)
Sample 1
Official No. Flag HERCULES 11 (formerly XXXXXX DRILLING 11-J) 617208 U.S. HERCULES 15 (formerly XXXXXX DRILLING 15-J) 650830 U.S. HERCULES 20 (formerly XXXXXX DRILLING 20-J) 619440 U.S. HERCULES 25 (formerly XXXXXX DRILLING 25-J) 625086 U.S. Exhibit B Credit Agreement and Notes (See Attached) EXHIBIT F-1 FORM OF GUARANTY AND PLEDGE AGREEMENT DATED AS OF JUNE 29, 2005 MADE BY HERCULES OFFSHORE, LLC AND EACH OF THE OTHER OBLIGORS (AS DEFINED HEREIN) IN FAVOR OF COMERICA BANK, AS ADMINISTRATIVE AGENT TABLE OF CONTENTS Page ARTICLE I
Sample 1
Official No. PORT OF REGISTRY: .......... .......................................
Sample 1
Official No. Title Case Status Case30-CA 2516702 *** Granted/Registered Case30-CN 03826014.X *** Granted/Registered Case30-EP 1500000 *** Xxxxxxx/Xxxxxxxxxx (XX, XX, GB) Case30-JP 4478034 *** Granted/Registered Case30-NZ 541596 *** Granted/Registered Case30-US 7666604 *** Granted/Registered Case30-ZA 2005/06516 *** Granted/Registered Case52-WO WO2005/113595 *** International phase complete Case52-AU 2005245664 *** Granted/Registered Case52-CA 2566363 *** Allowed Case52-CN 200580016449.6 *** Granted/Registered Case52-EP 1765860 *** Granted/Registered (CH, DE, DK, FR, GB, IE, NL) Case52-JP 4773434 *** Granted/Registered Case52-NZ 550810 *** Granted/Registered Case52-US 8143376 *** Granted/Registered Case52- 8008438 *** Granted/Registered ***Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission.
Sample 1
AutoNDA by SimpleDocs
Official No. Title Case Status GBprov Case120-WO PCT/GB2013/053320 *** Application filed Case121-USprov 61/953114 *** Application filed Case121-GBprov 1404536.3 *** Application filed Case123-GBprov 1405078.5 *** Application filed Case125-GBprov 1313377.2 *** Application filed Case126-USprov 61/894994 *** Application filed Case126-GBprov 1318804.0 *** Application filed ***Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. Schedule 4 PREVENTION OF CORRUPTION — THIRD PARTY GUIDELINES The GSK Anti-Bribery and Corruption Policy (POL-GSK-007) requires compliance with the highest ethical standards and all anti-corruption laws applicable in the countries in which GSK (whether through a Third Party or otherwise) conducts business. POL-GSK-007 requires all GSK employees and any Third Party acting for or on behalf of GSK to ensure that all dealings with third parties, both in the private and government sectors, are carried out in compliance with all relevant laws and regulations and with the standards of integrity required for all GSK business. GSK values integrity and transparency and has zero tolerance for corrupt activities of any kind, whether committed by GSK employees, officers, or third-parties acting for or on behalf of the GSK. Corrupt Payments — GSK employees and any Third Party acting for or on behalf of GSK, shall not, directly or indirectly, promise, authorise, ratify or offer to make or make any “payments” of “anything of value” (as defined in the glossary section) to any individual (or at the request of any individual) including a “government official” (as defined in the glossary section) for the improper purpose of influencing or inducing or as a reward for any act, omission or decision to secure an improper advantage or to improperly assist the company in obtaining or retaining business. Government Officials — Although GSK’s policy prohibits payments by GSK or third parties acting for or on its behalf to any individual, private or public, as a “quid pro quo” for business, due to the existence of specific anticorruption laws in the countries where we operate, this policy is particularly applicable to “payments” of “anything of value” (as defined in the glossary section), or at the request of, “government officials” (as defined in the glossary section). Facilitating Payments — For the avoidance of doubt, facilitating payments (otherwise known as “greasing payments” and defined as paymen...
Sample 1

Related to Official No

  • Official Time Duty time that is granted to representatives on behalf of the exclusive representative to perform representational functions without loss of pay or charge to an employee’s leave account. Official time will not be granted for internal union business, as defined by 5 USC 7131(b).

  • Official Language 1. All proceedings pursuant to this Agreement shall be conducted in the English language.

  • Official Languages (a) Appointments and transfers shall be subject to the Corporate Official Languages Policy, as it may be amended from time to time.

  • Official Secrets Acts The Contractor undertakes to abide and procure that the Contractor’s employees abide by the provisions of the Official Secrets Acts 1911 to 1989.

  • Official Record The Seller agrees that this Agreement is and shall remain at all times before the time at which this Agreement terminates an official record of the Seller as referred to in Section 13(e) of the Federal Deposit Insurance Act.

  • Publicity, Media and Official Enquiries 22.1 Without prejudice to the Authority’s obligations under the FOIA, neither Party shall make any press announcements or publicise the Contract or any part thereof in any way, except with the written consent of the other Party.

  • Official Use Only No Personal Use The Contract is only for official use by Authorized Users. Use of the Contract for personal or private purposes is strictly prohibited.

  • E6 Publicity, Media and Official Enquiries E6.1 The Contractor shall not:

  • School Official Designation Pursuant to Article I, Paragraph 1 of the DPA Standard Clauses, and in accordance with FERPA, ISSRA and SOPPA, in performing its obligations under the DPA, the Provider is acting as a school official with legitimate educational interest; is performing an institutional service or function for which the LEA would otherwise use its own employees; is under the direct control of the LEA with respect to the use and maintenance of Student Data; and is using Student Data only for an authorized purpose and in furtherance of such legitimate educational interest.

  • WITNESS my hand and official seal Signature of Notary (Affix seal in the above blank space) ================================================================================ EXHIBIT S-2 FORM OF POWER OF ATTORNEY FOR SPECIAL SERVICER RECORDING REQUESTED BY: GMAC COMMERCIAL MORTGAGE CORPORATION AND WHEN RECORDED MAIL TO: GMAC COMMERCIAL MORTGAGE CORPORATION 000 Xxxxxxxxxx Xxxxxx, 00xx Xxxxx Xxx Xxxxxxxxx, XX 00000 Attention: Commercial Mortgage Pass- Through Certificates Series 2005-HQ5 Space above this line for Recorder's use -------------------------------------------------------------------------------- LIMITED POWER OF ATTORNEY (SPECIAL) KNOW ALL MEN BY THESE PRESENTS, that XXXXX FARGO BANK, N.A., as trustee for Xxxxxx Xxxxxxx Capital I Inc., Commercial Mortgage Pass-Through Certificates, Series 2005-HQ5 ("Trustee"), under that certain Pooling and Servicing Agreement dated as of March 1, 2005 (the "Pooling and Servicing Agreement"), does hereby nominate, constitute and appoint GMAC COMMERCIAL MORTGAGE CORPORATION, as Special Servicer under the Pooling and Servicing Agreement ("GMAC"), as its true and lawful attorney-in-fact for it and in its name, place, stead and for its use and benefit: To perform any and all acts which may be necessary or appropriate to enable GMAC to service and administer the Mortgage Loans (as defined in the Pooling and Servicing Agreement) in connection with the performance by GMAC of its duties as Special Servicer under the Pooling and Servicing Agreement, giving and granting unto GMAC full power and authority to do and perform any and every act necessary, requisite, or proper in connection with the foregoing and hereby ratifying, approving or confirming all that GMAC shall lawfully do or cause to be done by virtue hereof.

Time is Money Join Law Insider Premium to draft better contracts faster.